Walsall extends The Beacon contract as treatment demand and retention climb
Walsall Council has approved arrangements for The Beacon, delivered by Change Grow Live, to continue providing specialist drug and alcohol treatment and recovery services for young people and adults across the borough from April 2027. The decision follows a review of service performance that points to rising demand, strong retention in care, and outcomes that compare favorably with national benchmarks.
The service sits at the center of Walsall’s response to substance use, where addiction rarely presents as a single diagnosis. It intersects with mental illness, unstable housing, family strain, criminal justice contact, unemployment, and preventable overdose. In that setting, continuity matters. A treatment pathway that keeps people engaged long enough to stabilize opioid use, manage alcohol dependence, and connect them with wider support can alter the trajectory of illness far beyond the clinic visit.
Recent activity figures show that more adults are accessing treatment. Numbers increased by 18.6% over the three years to 2025/26, compared with a 16.2% increase nationally. In 2025/26, 2,171 adults and young people accessed structured support through The Beacon. Those figures suggest a service under pressure, but also one drawing in more people who may otherwise have cycled through crisis care, emergency departments, and short-lived encounters with support services.
A service that can attract people early and keep them engaged is often the difference between ongoing harm and recovery.
Retention, recovery support, and the biology of staying in care
Treatment retention is one of the most clinically meaningful measures in substance use care because the benefits of intervention are cumulative. For opioid dependence, ongoing treatment can reduce overdose risk, curb chaotic use, and create a window for psychosocial recovery. For alcohol dependence, sustained engagement improves the chance of completing detoxification safely, managing relapse risk, and addressing nutritional, psychiatric, and social complications that build up over time.
In March 2026, 86.2% of adults remained in treatment for at least 12 weeks or successfully completed treatment within that period. The national average stood at 81.9%. In practical terms, that gap suggests The Beacon is not only reaching residents but also holding their attention long enough to deliver a meaningful clinical response. In addiction medicine, retention is not a bureaucratic metric. It is the point at which medication, counseling, harm reduction, and coordinated social care can begin to work together.
The service also offers support beyond direct prescribing. Its model includes harm reduction, employment help, family support, and specialist input for people with more complex needs. Those supports matter because substance use disorder is rarely isolated from the conditions that sustain it. Employment instability, fractured relationships, and poor physical health all feed relapse risk. Recovery-oriented care becomes more durable when those pressures are addressed alongside the addiction itself.
A needs assessment found that The Beacon is widely valued by residents and partner organizations. Users described staff as caring and compassionate, with a willingness to go the extra mile. Feedback was also positive about the treatment center at The Quarter in Walsall town center. The assessment concluded that the service continues to deliver strong outcomes and good value for money when compared with similar local authorities.
Same-day prescribing, prison transitions, and dual diagnosis care
Several recent service changes are likely to shape the next phase of care delivery. The introduction of rapid same-day prescribing for opioid treatment should shorten the delay between presentation and initiation of therapy. In addiction care, even a modest delay can be consequential. Patients at highest risk of overdose, withdrawal, or disengagement often have the least tolerance for repeated appointments before treatment starts. Faster access can reduce the period in which harm continues untreated.
The service has also improved prison in-reach support, increasing the number of people who continue treatment after release from prison. That transition is clinically fragile. Release from custody is a period of elevated overdose risk, and continuity of medication or follow-up can be lifesaving. A prison-to-community pathway that avoids interruption in care can prevent a predictable and often fatal break in treatment.
Work with Black Country Healthcare NHS Foundation Trust has strengthened support for people with both substance use and mental health issues, including the introduction of a specialist dual diagnosis nurse. Co-occurring mental illness is common in addiction services and can complicate assessment, prescribing, adherence, and recovery. Anxiety, depression, psychosis, trauma, and substance use often reinforce one another, and effective care depends on recognizing that overlap rather than treating each problem in isolation.
Naloxone access and overnight alcohol detox support come into focus
Under the new arrangements, The Beacon will keep its focus on preventing harm, supporting recovery, and tackling health inequalities across Walsall. Priority areas include expanding access to naloxone through peer-to-peer distribution, improving access to treatment and specialist support, strengthening engagement with residents through better communication, and introducing overnight support for people undertaking community-based alcohol detoxification.
Naloxone is central to contemporary overdose prevention because it rapidly reverses opioid toxicity. Wider community access increases the chance that a bystander can respond before an overdose becomes irreversible. Peer-to-peer distribution also reaches people who may not interact with formal health services regularly, which is especially relevant in populations with unstable housing or intermittent treatment contact.
Overnight support for community alcohol detoxification addresses another clinical risk point. Withdrawal can worsen outside conventional daytime service hours, and unmanaged symptoms can prompt relapse, emergency attendance, or unsafe self-management. Extending support into the night acknowledges a basic reality of detox care: risk does not follow office hours, and the period after evening dose changes or symptom escalation is often when people need the most reassurance and observation.
Councillor Matt Eason, Portfolio Holder for Culture, Health and Wellbeing, described The Beacon as a trusted and well-established service delivered by a compassionate and skilled workforce. He said it is reaching more people, retaining people in treatment, and achieving positive outcomes while providing good value for money. He also pointed to the service’s connections with health, housing, safeguarding, criminal justice, and community partners.
The current contract decision secures continuation, but the main questions now sit in implementation. Walsall must prove that broader naloxone access, faster prescribing, better prison transitions, and stronger dual diagnosis support can be sustained at scale while demand continues to rise. The next test is whether these service gains translate into fewer overdoses, fewer treatment dropouts, and more durable recovery across the borough.